Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-17

Clinical Trial Update: The Investigators Will Evaluate the Diagnostic Performance of [18F]-AlF-FAPI-74 PET/CT in Inflammatory Disorders and Compare it With the Current Gold Standard for Inflammation, FDG PET/CT, in Three Patient Cohort: Patients Presenting With Fever of Unknown Origin, IgG4-RD and AxSpA. [Phase 2, Phase 3]

View source ↗

Summary

The trial evaluates the diagnostic performance of the radiotracer [18F]-AlF-FAPI-74 PET/CT for inflammatory disorders and compares it with FDG PET/CT. It includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • [18F]AlF-FAPI-74 (FAPI-74 radiopharmaceutical labeled with Fluorine-18 via Aluminum-Fluoride complex)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Fever of Unknown Origin, IgG4 Related Disease | Phase 2, Phase 3 | Status: RECRUITING